SEC Form D · filed May 2, 2022
Facible BioDiagnostics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Micah Kormylo · MERIDIAN, IDExecMatthew Hawkins · MERIDIAN, IDDirectorClementine Gibard Bohachek · MERIDIAN, IDExecSteven Burden · MERIDIAN, IDExec · DirectorCasi Wyatt · MERIDIAN, IDDirectorBrent Fawson · MERIDIAN, IDExecEric Hayden · MERIDIAN, IDDirectorKenneth Bradley · Ottawa, Ontario, CanadaExecTravis M. Heriaud · Scottsdale, AZDirectorDan Geraci · Tucson, AZDirectorMark Tayles · Ottawa, Ontario, CanadaDirectorAlexander A. Wong · Denver, COExecShawn Bradley · Ottawa, Ontario, CanadaExecDanna M. Murphy · Scottsdale, AZExec · DirectorShaker J. Sadasivam · CAMBRIDGE, MADirectorMark G. Currie · CAMBRIDGE, MAExecPatrik Burnas · Stockholm, V7DirectorJosh G. Israel · Boston, MAExec · DirectorHanna C. Shuvalova · Chicago, ILExecDouglas Margerum · Bethesda, MDExecStephen Margerum · Bethesda, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗